DavidFKronnMD

Pediatrics • Valhalla, NY

Medical Genetics

Associate Professor, Pediatrics, New York Medical College

Join to view full profile

Dr. Kronn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kronn's full profile

Already have an account?

Office
503 Grasslands Rd
Ste 200
Valhalla, NY 10595
Phone+1 914-304-5280

Fax+1 914-345-1755

Education & Training

NYU Grossman School of MedicineResidency, Pediatrics, 1990 - 1996
University of Dublin Trinity CollegeClass of 1989

Certifications & Licensure

CT State Medical License 1998 - 2025
NY State Medical License 1993 - 2025
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2012-2014
America's Top Doctors Castle Connolly, 2012-2014
Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Westchester Magazine: Top Doctors Castle Connolly, 2009-2013
Join now to see all

Clinical Trials

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
Completed
Phase 3

Publications & Presentations

PubMed

2 citations
Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry.
Priya S Kishnani, David Kronn, Shugo Suwazono, Alexander Broomfield, Juan Llerena
Orphanet Journal of Rare Diseases. 2023-12-06
19 citations
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary...
Priya S Kishnani, David Kronn, Anaïs Brassier, Alexander Broomfield, James Davison
Genetics in Medicine. 2023-02-01
1 citations
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.
Tina Duong, Priya S Kishnani, Kristina An Haack, Meredith C Foster, James B Gibson
Journal of Neuromuscular Diseases. 2022-01-01

Press Mentions

Sanofi’s Next-Generation ERT Halts Progression of Pompe Disease in Patients, Interim Trial Data ShowFebruary 13th, 2020
High Prices for Orphan Drugs Strain Families and InsurersJanuary 17th, 2017
Sky-High Prices for Orphan Drugs Slam American Families and InsurersJanuary 17th, 2017